Article
[Efficacy of gefitinib for young patients with unknown EGFR gene mutation in advanced lung adenocarcinoma].
Zhongguo fei ai za zhi = Chinese journal of lung cancer - 1 May 2014
Liu Yutao, Shi Yuankai, Hu Xingsheng, Hao Xuezhi, Li Junling, Wang Ziping, Wang Yan, Wang Hongyu, Zhang Xiangru, Sun Yan
Abstract excerpt
BACKGROUND AND OBJECTIVE: Lung cancer in young patients (less or equal to 45 years) is relatively rare. We explored the efficacy and survival of Gefitinib for young patients with unknown epidermal growth factor receptor (EGFR) gene mutation of advanced lung adenocarcinoma. METHODS: The clinical data of 55 young patients with unknown EGFR gene mutation in advanced lung adenocarcinoma referred to the Cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.